Expression of EPHRIN-A1, SCINDERIN and MHC class I molecules in head and neck cancers and relationship with the prognostic value of intratumoral CD8+ T cells.

Abstract : BACKGROUND: Our group has previously shown that EPHRIN-A1 and SCINDERIN expression by tumor cells rendered them resistant to cytotoxic T lymphocyte-mediated lysis. Whereas the prognostic value of EPHRIN-A1 expression in cancer has already been studied, the role of SCINDERIN presence remains to be established. In the present work, we investigated the prognosis value of EPHRIN-A1 and SCINDERIN expression in head and neck carcinomas. In addition, we monitored the HLA-class I expression by tumor cells and the presence of tumor-infiltrating CD8+ T cells to evaluate a putative correlation between these factors and the survival prognosis by themselves or related to EPHRIN-A1 and SCINDERIN expression. METHODS: Tumor tissue sections of 83 patients with head and neck cancer were assessed by immunohistochemistry for the expression of EPHRIN-A1, SCINDERIN, HLA class I molecules and the presence of CD8+ T cells. RESULTS: No significant prognosis value could be attributed to these factors independently, despite a tendency of association between EPHRIN-A1 and a worse clinical outcome. No prognostic value could be observed when CD8+ T cell tumor infiltration was analyzed combined with EPHRIN-A1, SCINDERIN or HLA class I expression. CONCLUSION: These results highlight that molecules involved in cancer cell resistance to cytotoxic T lymphocytes by themselves are not a sufficient criteria for prognosis determination in cancer patients. Other intrinsic or tumor microenvironmental features should be considered in prognostic evaluation.
Type de document :
Article dans une revue
BMC Cancer, BioMed Central, 2013, 13 (1), pp.592. 〈10.1186/1471-2407-13-592〉
Liste complète des métadonnées

Littérature citée [59 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00920614
Contributeur : Ed. Bmc <>
Soumis le : mercredi 18 décembre 2013 - 21:01:44
Dernière modification le : mercredi 28 mars 2018 - 13:16:01
Document(s) archivé(s) le : jeudi 20 mars 2014 - 11:26:52

Fichiers

Identifiants

Collections

Citation

Meriem Hasmim, Cécile Badoual, Philippe Vielh, Françoise Drusch, Virginie Marty, et al.. Expression of EPHRIN-A1, SCINDERIN and MHC class I molecules in head and neck cancers and relationship with the prognostic value of intratumoral CD8+ T cells.. BMC Cancer, BioMed Central, 2013, 13 (1), pp.592. 〈10.1186/1471-2407-13-592〉. 〈inserm-00920614〉

Partager

Métriques

Consultations de la notice

630

Téléchargements de fichiers

271